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Abstract. Incidence of primary intracranial tumour in pregnancy is very rare. This rare association  is becoming more 
common because women in developed societies defer childbearing to the third or fourth decade of life. We presented A 
case of a 33- year-old, gravida 2 para 1, Indonesian Acehnese women presented with pregnancy and recurrent 
Glioblastoma. Her chief complaint was headache that is worsening since 1 month ago. She is a patient of Neurosurgery 
Department since 7 months earlier with complaints of major headache, vomitting,  seizure and weakness of the left part 
of her body when she was 12 weeks pregnant. Patients was diagnosed with brain tumor on right temporoparietal region. 
Her CT scan result are midline shift to the left of falx cerebri with obliterated right ventricle and hypodens mass on right 
region size 5,04x 5,17 cm x 5,79 cm. Craniotomy was performed with no regards of the pregnancy but the patient refuse 
to terminate the pregnancy. Post craniotomy patient was supposed to undergo series of radiotherapy but decided not to 
since it may complicate her pregnancy. After 5 month went untreated, patient then had another CT scan due to her 
recurring complaint and the result was there’s an area of hypo and hyperdens in fronto parietal dextra and sinistra with 
brain edema. The patient was treated for a week when her condition was worsening with loss of consciousness. We then 
perfomed joint operation with Neurosurgery dept consist of Cesarean section that was continued with craniotomy where 
we delivered a heathy 1900 gram baby boy. The patient was then treated for 2 days in the intensive care unit and 
another 4 days in the ward then discharged home in good condition. Every brain tumours in pregnancy bring  dilemmas 
with no standard treatment in medicine.  Its diagnosis  is challenging because of the need to treat the mother and 
minimizing the effects of cancer treatment on the fetus. The treatment intention is  to minimise mortality and morbidity 
for both maternal and fetal which can be achieved by prolonging pregnancy while alleviating complications from the brain 
tumour. The management have to be individualised  from a multi-disciplinary team and the consideration of a multitude 
of factors, including nature and location of the tumour, associated signs and symptoms, fetal gestation and the patient’s 
wishes. 
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Introduction  
The incidence of primary intracranial tumour in pregnancy is only 0.36 per 100 000 
births.1 As women in developed societies defer childbearing to the third or fourth decade of life, 
this rare association is likely to become more common.2 Although considered as the most 
common intracranial tumour, glioblastoma multifome has an incidence of only 1 in 33 330 in the 
general population and carry prognosis of approximately 14 months.3  Glioblastomas are a 
heterogeneous group of neoplasms that comprise the majority of tumors originating in the 
central nervous system (CNS).4  Although there are no increased incidence of brain tumors in 
pregnancy, the initial manifestation, especially gliomas, has been found to occur during the first 
trimester 4 It has been noted that pregnancy often masks the presence of an intracranial 
neoplasm, and that the risk of misdiagnosis is high. This is because symptoms such as headache, 
vomiting, visual disturbance are often encountered in pregnancy. Here we present the case 
report of a recurrent glioblastoma multiforme in pregnancy. 
 
Material and Methods 
History, examination and management 
A 33- year-old, gravida 2 para 1, Indonesian Acehnese women presented with pregnancy 
and recurrent Glioblastoma. Her chief complaint was headache that is worsening since 1 month 
ago. She is a patient of Neurosurgery Deartment since 7 months earlier with complaints of major 
headache, vomitting,  seizure and weakness of the left part of her body when she was 12 weeks 
pregnant. Patients was diagnosed with brain tumor on right temporoparietal region. Her CT scan 
result are midline shift to the left of falx cerebri with obliterated right ventricle and hypodens 
mass on right region size 5,04x 5,17 cm x 5,79 cm. (Fig 1). Craniotomy was performed with no 
regards of the pregnancy but the patient refuse to terminate the pregnancy. Post craniotomy 
patient was supposed to undergo series of radiotherapy but decided not to since it may 
complicate her pregnancy. After 5 month went untreated, patient then had another CT scan due 
to her recurring complaint and the result was there’s an area of hypo and hyperdens in fronto 
parietal dextra and sinistra with brain edema (Figure 2).   
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Fig 1. CT scan result before the first operation   Fig 2. CT scan result when the Glioblastoma is recurring 
                                                                              (A) compared to the post op result (B) 
 
The patient was treated for a week when her condition was worsening with loss of consciousness. 
We then perfomed joint operation with Neurosurgery dept consist of Cesarean section that was 
continued with craniotomy. (Figure 3)  We delivered a healthy 1900 gram baby boy. (Figure 4) .  
The patient was then treated for 2 days in the intensive care unit and another 4 days in the ward 
then discharged home in good condition.  
 
Fig 3. Joint operation between OBGYN  and Neurosurgery depart         Fig 4. A hea;thy 1900 g baby boy  
 
 
Results and Discussion 
In 2009, the American Cancer Society estimated that one in four deaths in the United 
States was due to cancer and that cancer was the second most common cause of death during 
reproductive years.5 As women tend to delay childbearing to the third decade of life, the 
incidence of gestational cancer is expected to increase.5 Of the 18,820 new cases of primary 
central nervous system tumors diagnosed annually in the United States, gliomas account for over 
60% with 30-40% of them being glioblastoma multiforme, 10% being anaplastic astrocytoma , 
and 10% being low grade gliomas .4   The most common malignancies associated with pregnancy 
are reported to be breast cancer, cervical cancer, melanoma, thyroid and Hodgkin’s lymphoma 
with less frequent malignancies are leukemia, ovarian, lung and gastrointestinal cancers 5 An 
alternative explanation for the reduced occurrence of primary intracranial neoplasms in pregnant 
patients may lie not in the patterns of tumour growth but in reduced fertility of patients with 
preclinical or undiagnosed brain tumours.6  
The concurrence of a brain tumour and pregnancy constitutes a clinical problem with 
symptoms such as headache, vomiting and visual disturbance where it is  common to both brain 
tumours and pregnancy, and convulsions caused by a brain tumour may falsely considered due 
to eclampsia. 7 Common presenting symptoms include generalised symptoms such as headache, 
nausea and vomiting, seizures, syncope and cognitive dysfunction. Common focal symptoms 
include visual, language, motor and sensory disturbances. 8-9  Our patient had recurring 
symptoms of of major headache and vomitting. Since it wa early in the pregnancy, a lot of 
medical doctor that she had visited thought of it as only minor clinical pregnancy complaints. 
When she complaints of  seizure and weakness of the left part of her body, that was when her 
doctor realized it and have it checked. . Her CT scan result are midline shift to the left of falx 
cerebri with obliterated right ventricle and hypodens mass on right region size 5,04x 5,17 cm x 
5,79 cm. 
It has been shown that pregnancy predisposes the brain to edema formation by 
upregulation of a type of channel forming trans-membrane protein called Aquaporin-4 This 
protein facilitates the movement of water, glycerol and other solutes across plasma membrane. 
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The likelihood of blood-brain barrier disruption in the presence of neoplasm, further increases the 
likelihood of edema formation and could become worsened if eclampsia is present 5 Others 
thought that  pregnancy does not increase the growth rate of tumour cells; and, enlargement of 
tumour size is considered to be a consequence of engorgement of the blood vessels which feed 
the tumour, or to a state of positive water balance as a result of the altered hormonal 
environment accompanying pregnancy.7  In some tumours, such as meningioma, pituitary 
adenomas and angiomas, however, estrogen and/or progesterone induced proliferation of 
tumour cells during pregnancy.7 
When considering termination of pregnancy, qualified and teamed medical personnel 
should inform patients about the risks for their health and for the fetus from anti-neoplastic 
therapy administered during pregnancy.5   The management is complicated by the need to 
consider induced abortion, mode of delivery, neurosurgical management, and adjuvant treatment 
including radiation therapy to the mother.7 Management should be individualised depend on the 
patient's symptoms and signs, the nature and site of the tumour and the stage of pregnancy. In 
stable patients with non-life threatening tumours, such as benign supratentorial tumours without 
any evidence of increased intracranial pressure, management should be based on obstetric 
criteria 7 In patients whose condition rapidly deteriorates, or in whom the brain tumour is 
malignant, the management  should be different from that of patients in a stable condition. 
Definitive tumour treatment may be required before delivery and, in the worst case, pregnancy 
may not be allowed to continue.7  
There are no guidelines for the adjuvant administration of chemotherapy or radiotherapy 
or the ideal timing of neurosurgical or obstetrical intervention in pregnant women.10 Because of 
the relative paucity of reported cases of gliomas diagnosed and treated during pregnancy, the 
literature right now comprises only case reports and small series.10   The treatment of malignant 
gliomas requires a multidisciplinary approach. Current standards of practice for treating newly 
diagnosed high-grade glioma include maximal safe resection followed by radiotherapy, and, in 
the instance of newly diagnosed glioblastoma, adjuvant chemotherapy.10 A patient who presents 
during the first or early second trimesters may be considered for neurosurgery as the fetus is 
remote from viability. Radiotherapy, radiosurgery and image-guided surgery may also be an 
option after the fi rst trimester. Benefits of anti-epileptic medications to control maternal 
symptoms outweigh their risks of teratogenicity and should not be withheld.8 Increased 
intracranial pressure can occur from the added effects of pressure from the exertions of labor 
upon the tumor and associated peritumoral edema.  This scenario is more of a concern in an 
undiagnosed, untreated patient. In the case of a symptomatic tumor,an elective Caesarean 
section should be encouraged.10 Major operations can be safely performed throughout gestation 
without increased maternal risk, but a 1–3% risk of foetal loss and aminimally increased relative 
risk (1.5–2.0) for low birth weight and premature delivery exits. 2 
After the first operation, the patient was supposed  to underwent radiation with abdominal 
shielding. But the patient refused to do so. And after 5 month went untreated, patient then had 
another CT scan due to her recurring complaint and the result was there’s an area of hypo and 
hyperdens in fronto parietal dextra and sinistra with brain edema.  The patient was treated for a 
week when her condition was worsening with loss of consciousness when we finally decided to 
perform joint operation cesarean section and continued with craniotomy. 
The usage of radiation  effect differ correlate to  gestation age. During the pre-
implantation and implantation period  the ‘‘all or nothing’’ rule applies where irradiation of the 
undifferentiated embryo results in either death or normal development and doses as low as 100 
mGy can cause embryonic death, with a reported incidence of 50% with doses of 1 Gy. During 
the period of organogenesis (weeks 3–12), embryonic death or developmental malformations are 
frequent with radiation doses of 1 Gy and may occur with doses as low as 50–250 mGy. The 
foetal dose of 100 mGy (10 rad) during the first trimester is frequently cited as a ‘‘threshold 
dose’’ for the risk of teratogenesis. Exposure to 250 mGy or higher doses of ionizing radiation 
during the second and third trimesters is associated with growth retardation, mental retardation, 
malformations of late-forming tissues (central nervous system, gonads) and premature birth.2  
A dose of 2.2 cGy adds a risk of fatal cancer by the age 15 years of only 1 in 1500. 
Because the addition of shielding might halve the fetal dose, this risk should be reduced to 1 in 
3000.11 For the fetus, these detrimental effects include congenital malformations, potential 
carcinogenesis, organ toxicity, prematurity, impaired fetal weight gain, growth retardation, and 
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developmental delay. For the mother, chemotherapy associated risks include stillbirth, 
spontaneous abortion, and maternal sterility. 10 
 
Conclusions  
Every brain tumours in pregnancy bring  dilemmas with no standard treatment in 
medicine.  Its diagnosis  is challenging because of the need to treat the mother and minimizing 
the effects of cancer treatment on the fetus. The treatment intention is  to minimise mortality 
and morbidity for both maternal and fetal which can be achieved by prolonging pregnancy while 
alleviating complications from the brain tumour.  
The management have to be individualised  from a multi-disciplinary team and the 
consideration of a multitude of factors, including nature and location of the tumor, associated 
signs and symptoms, fetal gestation and the patient’s wishes. 
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